Profile
Nick Pizzie is the Chief Financial Officer of Axsome Therapeutics, Inc., as indicated by an SEC filing dated January 24, 2026 (CIK 0001742143). The filing shows no purchases or sales by Pizzie in that period and lists him as the CFO of Axsome, a clinical-stage biopharmaceutical company focused on CNS disorders. Based on the SEC context, Pizzie is a financial executive responsible for Axsome's financial reporting and capital management.
| Role | Insider |
|---|
| Notability | 40/100 |
|---|
Board memberships
- Axsome Therapeutics, Inc.
Awards & honors
- Oversight of Axsome's financial reporting and treasury functions as CFO
- Participation in financing activities to support Axone's CNS portfolio
Frequently Asked Questions
Who is Pizzie Nick?
Nick Pizzie is the Chief Financial Officer of Axsome Therapeutics, Inc., as indicated by an SEC filing dated January 24, 2026 (CIK 0001742143). The filing shows no purchases or sales by Pizzie in that period and lists him as the CFO of Axsome, a clinical-stage biopharmaceutical company focused on CNS disorders. Based on the SEC context, Pizzie is a financial executive responsib…
How many SEC Form 4 filings has Pizzie Nick submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Pizzie Nick been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($10.18M) across all tracked filings.
Where can I see all of Pizzie Nick's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.